About 6 100 reports

A recent market study published on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022–2032. The study offers a comprehensive assessment of the more important market dynamics. After conducting thorough research on the historical and current growth parameters of the CNS Treatment and Therapy Market,...

  • Mental Health
  • Antipsychotic
  • World
  • Latin America
  • North America
  • Western Europe
  • Eastern Europe
  • Japan

China’s demand for HIV Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...

  • HIV Antiviral
  • China
  • Industrial Production
  • Hospital Beds Number

The hyperhidrosis treatment market studied is anticipated to grow with a CAGR of 6.2% during the forecast period. The major factors attributing to the growth of the hyperhidrosis treatment market are a rise in the prevalence of secondary hyperhidrosis conditions and an increase in investments by players for research and development. According...

  • Dermatological Condition
  • Therapy
  • World
  • Health Expenditure
  • Diabetes Prevalence

MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing...

  • Therapy
  • World
  • North America
  • Europe
  • APAC
  • Health Expenditure
  • Cancer Incidence

China’s demand for Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer...

  • Oncology
  • China
  • Industrial Production
  • Labour Force

The skincare treatment devices market is projected to reach US$ 23,378.96 million by 2028 from US$ 10,898.26 million in 2021; it is estimated to grow at a CAGR of 11.5% during 2021-2028. Increasing prevalence of skin disorders and rising awareness about beauty devices, along with increasing new product launches and rising developments...

  • Therapy
  • Skin Care
  • World
  • Disposable Income
  • Health Expenditure

5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) - 5-Hydroxytryptamine receptor...

  • Pharmaceutical
  • Drug Development
  • Hormone
  • World
  • Drug Approval
  • Health Provider Density

The hematuria treatment market is projected to reach US$ 1,103.61 million by 2028 from US$ 932.89 million in 2021; it is estimated to grow at a CAGR of 2.4% from 2021 to 2028. Factors such as the high prevalence of hematuria-associated indications, and increasing awareness about treatment options and improving healthcare expenditure are driving...

  • Therapy
  • Genitourinary System Disease
  • World
  • APAC
  • Health Expenditure
  • Mortality Rate

China’s demand for Pneumonia Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer...

  • Therapy
  • Infectious Disease
  • China
  • Prescription Drug Sales
  • Industrial Production

The global rotator cuff injury treatment market is projected to reach USD 1,244 million by 2026 from USD 989 million in 2021, at a CAGR of 4.7% during the forecast period”. The key factors fueling the growth of this market include an increase in sports related shoulder injuries, technological advancements in arthroscopic surgical devices,...

  • Therapy
  • World
  • United States
  • North America
  • Europe
  • APAC
  • Drug Approval
  • Sports Participation Rate

Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Exportin 1 - Drugs In Development, 2022’; Exportin 1 (Chromosome...

  • Therapy
  • Drug Development
  • World
  • Drug Approval
  • Direct Sales

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Alpha L-Iduronidase - Drugs In Development, 2022’; Alpha L-Iduronidase (IDUA or EC 3.2.1.76)...

  • Therapy
  • Endocrine Disease
  • Drug Development
  • World
  • Pharmaceutical Exports
  • Life Expectancy

Coronavirus (COVID-19) Current Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change provides the strategists; marketers and senior management with the critical information they need to assess the global coronavirus (COVID-19) current therapy market as it emerges from the COVID 19 shut down. Description: Where...

  • Infectious Disease
  • Therapy
  • World
  • Public Health Expenditure
  • Private Health Expenditure

Photodynamic Therapy Global Market Opportunities And Strategies To 2031: COVID-19 Implications And Growth provides the strategists; marketers and senior management with the critical information they need to assess the global photodynamic therapy market as it emerges from the COVID 19 shut down. Description: Where...

  • Therapy
  • Infectious Disease
  • World
  • Health Expenditure
  • Gross Domestic Product Per Capita

The global Pigmentation Disorders Treatment Market was valued at USD 5,591.98 million in 2020, and it is expected to reach USD 8,593.68 million by 2026, registering a CAGR of 7.14% during the forecast period. The COVID-19 has impacted the pigmentation disorder treatment market. According to a survey by Hamilton Fraser Cosmetic Insurance,...

  • Therapy
  • Dermatological Condition
  • World
  • Health Expenditure
  • Number Of Enterprises

Spinal Cord Stimulators (SCS) - Medical Devices Pipeline Product Landscape, 2021 Summary Medical Devices sector report, “Spinal Cord Stimulators (SCS) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Spinal Cord Stimulators (SCS) pipeline products...

  • Clinical Trial
  • Therapy
  • United Kingdom
  • Direct Sales
  • Medical Devices Sales

Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Hepcidin (Liver Expressed Antimicrobial...

  • Therapy
  • World
  • Iron Export
  • Hospital Occupancy Rate

China’s demand for Colon Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer...

  • Oncology
  • China
  • Industrial Production
  • Labour Force

Coronavirus (COVID-19) Current Therapy Global Market Opportunities And Strategies To 2031: COVID-19 Impact and Recovery provides the strategists; marketers and senior management with the critical information they need to assess the global coronavirus (COVID-19) current therapy market as it emerges from the COVID-19 shut down. Description: Where...

  • Infectious Disease
  • Therapy
  • World
  • Public Health Expenditure
  • Private Health Expenditure

Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Drugs in Development, 2021 Summary Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) pipeline Target constitutes close to 9 molecules. Out of which approximately...

  • Pharmaceutical
  • Cancer
  • Oncology
  • Prostate Cancer
  • World
  • Drug Approval

Muscarinic Acetylcholine Receptor M2 (CHRM2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Muscarinic Acetylcholine Receptor M2 (CHRM2) pipeline Target constitutes close to 10 molecules. Out of which approximately 10 molecules...

  • Pharmaceutical
  • Therapy
  • Drug Development
  • World
  • Diagnostic Imaging Density
  • Drug Approval

The anaphylaxis treatment market is expected to reach US$ 4,787.66 million in 2028 from US$ 2,664.66 million in 2021; it is estimated to grow at a CAGR of 8.7% during 2021–2028. The growth of the market is mainly attributed to the key driving factors such as the rising incidence of anaphylaxis, and recent approvals of epinephrine. However,...

  • Therapy
  • World
  • APAC
  • Europe
  • Allergy Prevalence
  • Retail Revenue

The anaphylaxis treatment market in Asia Pacific is expected to grow from US$ 350.7 million in 2021 to US$ 664.0 million by 2028; it is estimated to grow at a CAGR of 9.6% from 2021 to 2028. Novel drug delivery systems support improved drug potency and controlled drug release, along with imparting a sustained therapeutic effect for...

  • Therapy
  • APAC
  • Retail Revenue
  • Allergy Prevalence

China’s demand for Depression Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer...

  • Antidepressant
  • Depression
  • China
  • Industrial Production
  • Labour Force

Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABA(A) Receptor Subunit Alpha 2 or GABRA2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABA(A) Receptor Subunit Alpha...

  • Therapy
  • Chronic Pain
  • World
  • Diagnostic Imaging Density

The anaphylaxis treatment market in Europe is expected to grow from US$ 534.0 million in 2021 to US$ 987.2 million by 2028; it is estimated to grow at a CAGR of 9.2% from 2021 to 2028. Anaphylaxis is a severe, life?threatening allergic reaction caused by vulnerability to allergens (foods, insect stings, or medicines) identified as a...

  • Therapy
  • Europe
  • Retail Revenue
  • Allergy Prevalence

The global prostate health market is projected to reach USD 48.9 billion by 2026 from USD 31.8 billion in 2021, at a CAGR of 9.0% during the forecast period. The prostate gland (the prostate) is an organ of the male reproductive system. The three most common forms of prostate disease are inflammation (prostatitis), non-cancerous enlargement...

  • Therapy
  • World
  • North America
  • Europe
  • United States
  • APAC
  • Overweight Prevalence
  • Health Expenditure

Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Histone Deacetylase 4 - Drugs In Development, 2022’; Histone Deacetylase...

  • Cancer
  • Therapy
  • Drug Development
  • Gene Therapy
  • Heart Failure
  • World
  • Stem Cell Transplantation

The anaphylaxis treatment market in North America is expected to grow from US$ 1,635.8 million in 2021 to US$ 2,891.7 million by 2028; it is estimated to grow at a CAGR of 8.5% from 2021 to 2028. Cases of allergies have been observed after the COVID-19 vaccination. As of December 23, 2020, 1.5 million people received the first dose...

  • Therapy
  • North America
  • Retail Revenue
  • Drug Approval

The anaphylaxis treatment market in Middle East and Africa is expected to grow from US$ 52.2 million in 2021 to US$ 87.1 million by 2028; it is estimated to grow at a CAGR of 7.6% from 2021 to 2028. Cases of allergies have been observed after the COVID-19 vaccination.Along with this, patients with an anaphylaxis history should carry...

  • Therapy
  • Middle East
  • Africa
  • Retail Revenue
  • Allergy Prevalence